Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
[kallmann syndrome]
Insulin
-like
factor
3
(
INSL
3
)
is
a
testicular
hormone
secreted
during
fetal
life
,
the
neonatal
period
,
and
after
puberty
.
To
measure
INSL
3
levels
in
a
large
series
of
men
with
congenital
hypogonadotropic
hypogonadism
(
CHH
)
/
Kallmann
syndrome
(
KS
)
,
in
order
to
assess
its
diagnostic
value
and
to
investigate
its
regulation
.
We
studied
281
CHH
/
KS
patients
(
91
untreated
,
96
receiving
T
,
and
94
receiving
combined
gonadotropin
therapy
[
human
chorionic
gonadotropin
,
hCG
,
and
FSH
]
)
and
72
age-matched
healthy
men
.
Serum
INSL
3
was
immunoassayed
with
a
validated
RIA
.
Mean
(
±
SD
)
INSL
3
levels
(
pg
/
mL
)
were
659
±
279
in
controls
and
lower
(
60
±
43
;
P
<
.
001
)
in
untreated
CHH
/
KS
patients
,
with
no
overlap
between
the
two
groups
,
when
the
threshold
of
250
pg
/
mL
was
used
.
Basal
INSL
3
levels
were
lower
in
both
untreated
CHH
/
KS
men
with
cryptorchidism
than
in
those
with
intrascrotal
testes
and
in
patients
with
testicular
volumes
below
4
mL
.
Significant
positive
correlations
between
INSL
3
and
both
serum
total
T
and
LH
levels
were
observed
in
untreated
CHH
/
KS
.
Mean
INSL
3
levels
remained
low
in
T
-
treated
CHH
/
KS
patients
and
were
significantly
higher
in
men
receiving
combined
hCG-FSH
therapy
(
P
<
.
001
)
,
but
the
increase
was
lower
cryptorchid
patients
.
FSH-hCG
combination
therapy
or
hCG
monotherapy
,
contrary
to
T
and
FSH
monotherapies
,
significantly
increased
INSL
3
levels
in
CHH
/
KS
.
INSL
3
is
as
sensitive
a
marker
as
T
for
the
evaluation
of
altered
Leydig
cell
function
in
CHH
/
KS
patients
.
INSL
3
levels
correlate
with
LH
levels
in
CHH
/
KS
men
showing
,
together
with
the
rise
in
INSL
3
levels
during
hCG
therapy
,
that
INSL
3
secretion
seems
not
constitutively
secreted
during
adulthood
but
is
dependence
on
pituitary
LH
.
Diseases
Validation
Diseases presenting
"fetal life"
symptom
aromatase deficiency
congenital adrenal hyperplasia
congenital diaphragmatic hernia
congenital toxoplasmosis
harlequin ichthyosis
hirschsprung disease
kallmann syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom